<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20161124031068N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-21</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of early mobilization on clinical index in respiratory failure</public_title>
      <acronym></acronym>
      <scientific_title>The effect of early mobilization on clinical index in patients with respiratory failure undergoing mechanical ventilation in intensive care units</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-06-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/47600</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Patients are divided into control and intervention groups based on the random allocation of double blocking. To do this, the 4 blocks will be selected so that they will belong to the letter A intervention group and the letter B control group. 6 probable states are written on separate cards and one number (from one to six) will be assigned to each card, then the numbers will be written on paper and randomly removed.Until the expected number of samples is completed. In this study, online randomization service (https://www.sealedenvelope.com/simple-randomiser/v1/lists) will be used for randomized block allocation.Allocation concealment  will be done using closed envelopes, so that one letter is placed inside each envelope in the specified order, and then the envelope lid will be closed and provided to the researcher.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Respiratory Failure.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:The intervention designed for this study is a standard 4-level protocol. In the first level, the range of motion of the joints is performed on non-conscious patients and five times on each joint. At the second level, the physiotherapy protocol begins.The patient must answer three of the commands so that the researcher realizes that she/he is ready to enter the next stage.Open your eyes, look at me, open your mouth and stick out your tongue, raise and lower your head, raise your eyebrows when you hear the number 5. If the patient responds to three of the researcher's five requests, his or her condition is appropriate for initiating physiotherapy. When the patient finds sufficient strength and alertness to participate in occupational therapy, he or she will be moved toward two active recipient approaches or active range of motion. They move from level 2 to 4.Measures taken at this level include changing the position every 2 hours, inactive movement of the joint area 3 times a day, and the patient should be placed in a fully sitting position for at least 2 times for 20 minutes.All second-level measures are also performed at levels 3 and 4. The upgrade from level 2 to 3 and from 3 to 4 depends on the score that the patient receives from the MRC criterion in terms of muscular strength in one attempt.A score of 3 out of 5 on the biceps is required to enter level 3 and a score of 3 out of 5 on the quadriceps is required to enter level 4. As the patient progresses, activities should focus on a variety of functions such as sitting on the edge of the bed, getting out of bed, sitting in a balanced position, and pre-starting exercises such as weight transfer on the legs or walking and moving. The implementation of this protocol in the form of interdisciplinary and team work with the cooperation of the members of this team will include a researcher, physiotherapist, physician in charge of ICU and assistant to the ward assistant. Intervention 2: Control group: In this study, the control group will receive the usual care of the ward. The usual care of the section under study in this study is to change the position once or twice in each shift.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data will be shared.

When:
starting 6 months after publication.

To whom:
Researchers working in academic and scientific institutions

Conditions:
There is no limitation.

Where to obtain:
Email address.

How to obtain:
Documents will be sent via email after the work is completed and 6 months after the article is published.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maryam Esmaeili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Central Organization, Tehran University of Medical Sciences, Quds Street, Keshavarz Boulevard</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6105 4000</telephone>
        <email>esmaeili_m@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maryam Esmaeili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Central Organization, Tehran University of Medical Sciences, Quds Street, Keshavarz Boulevard</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6105 4000</telephone>
        <email>esmaeili_m@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Passing 48 hours after intubation and mechanical ventilation
-3 &lt; RASS &lt; 2
Hemodynamic situation stability
PEEP &lt; 8
Fio2 &lt; 60
Spo2 &gt; 89
12 &gt; RR &gt; 30
60 &lt; MAP &gt; 110</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Psychosomatic disorder
Any mobility disfunction
Acute cerebral strock
BMI&gt;40
Femour fracture
After CPR</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J96.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Respiratory failure, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:The intervention designed for this study is a standard 4-level protocol. In the first level, the range of motion of the joints is performed on non-conscious patients and five times on each joint. At the second level, the physiotherapy protocol begins.The patient must answer three of the commands so that the researcher realizes that she/he is ready to enter the next stage.Open your eyes, look at me, open your mouth and stick out your tongue, raise and lower your head, raise your eyebrows when you hear the number 5. If the patient responds to three of the researcher's five requests, his or her condition is appropriate for initiating physiotherapy. When the patient finds sufficient strength and alertness to participate in occupational therapy, he or she will be moved toward two active recipient approaches or active range of motion. They move from level 2 to 4.Measures taken at this level include changing the position every 2 hours, inactive movement of the joint area 3 times a day, and the patient should be placed in a fully sitting position for at least 2 times for 20 minutes.All second-level measures are also performed at levels 3 and 4. The upgrade from level 2 to 3 and from 3 to 4 depends on the score that the patient receives from the MRC criterion in terms of muscular strength in one attempt.A score of 3 out of 5 on the biceps is required to enter level 3 and a score of 3 out of 5 on the quadriceps is required to enter level 4. As the patient progresses, activities should focus on a variety of functions such as sitting on the edge of the bed, getting out of bed, sitting in a balanced position, and pre-starting exercises such as weight transfer on the legs or walking and moving. The implementation of this protocol in the form of interdisciplinary and team work with the cooperation of the members of this team will include a researcher, physiotherapist, physician in charge of ICU and assistant to the ward assistant.</i_keyword>
      <i_keyword>Control group: In this study, the control group will receive the usual care of the ward. The usual care of the section under study in this study is to change the position once or twice in each shift.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Respiratory index. Timepoint: Before the start, the end of the first day, the end of the second day, the end of the third day. Method of measurement: Arterial blood gas and monitoring system.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Duration of hospital stay in ICU and duration of mechanical ventilation. Timepoint: Mechanical ventilation weaning and discharge from ICU. Method of measurement: Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-28</approval_date>
        <contact_name>Ethics Committee in Research, School of Nursing and Midwifery, and Faculty of Rehabilitation, Tehran</contact_name>
        <contact_address>Nosrat St.,Tohid Sq.,Tehran,Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
